Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Apr 15;12(4):e8574.
doi: 10.1002/ccr3.8574. eCollection 2024 Apr.

Single-dose ibuprofen induced Stevens-Johnson Syndrome

Ahmed Qasim Mohammed Alhatemi  1 , Hashim Talib Hashim  2 , Muhamad Abdulrahman Shyea Al-Tarbosh  1 , Rand Abdulhussain  3 , Ali Talib Hashim  4
Affiliations
Case Reports

Single-dose ibuprofen induced Stevens-Johnson Syndrome

Ahmed Qasim Mohammed Alhatemi et al. Clin Case Rep. .

Abstract

Key clinical message: Ibuprofen single dose may rarely induce Stevens-Johnson Syndrome, emphasizing the vital need for heightened vigilance in healthcare and public awareness for safer medication practices.

Abstract: Stevens-Johnson Syndrome (SJS) is a severe and potentially life-threatening skin disorder associated with certain medications, including ibuprofen. We present a case of a 45-year-old woman who developed SJS following a single dose of ibuprofen. Despite its rarity, this case underscores the importance of heightened vigilance in healthcare and public awareness regarding the potential risks of commonly used medications. Prompt recognition of SJS symptoms and immediate medical intervention are crucial for patient outcomes. Healthcare providers should exercise caution when prescribing ibuprofen, particularly in patients with a history of adverse drug reactions. This case emphasizes the need for ongoing monitoring, patient education, and informed decision-making to promote medication safety and optimal patient care.

Keywords: acute medicine; critical care medicine; dermatology; immunology; pharmacology and pharmacy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
Conjunctivitis with discharge. Coalescing red erythematous macules with central blister formation in the face. Chelitis and yellowish discharge.
FIGURE 2
FIGURE 2
Nonblenching flat purpuric rash with target lesions in lower and upper limbs.
FIGURE 3
FIGURE 3
Initial Chest X‐ray PA view labeled as normal.
FIGURE 4
FIGURE 4
Skin biopsy histopathology specimen showing full‐thickness necrosis and separation of the epidermis at the dermoepidermal junction.
FIGURE 5
FIGURE 5
Decrease in size and color of facial rash with minimal ulcers and normal lips appearance 2 months after admission.
See this image and copyright information in PMC

References

    1. Pieper S. Fluoroquinolone‐associated disability (FQAD)‐pathogenesis, diagnostics, therapy and diagnostic criteria: side‐effects of Fluoroquinolones. Springer Nature; 2021.
    1. Fazeli SA, Abbasi M, Jalali H, et al. Bullous fixed drug eruption following ibuprofen ingestion. J Res Pharm Pract. 2018;7(1):51‐56. - PMC - PubMed
    1. Mawson AR, Eriator I, Karre S. Stevens‐Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role? Med Sci Monit. 2015;21:133. - PMC - PubMed
    1. Mancano MA. ISMP adverse drug reactions: propofol‐related infusion syndrome (PRIS) 1, 2; Ivermectin‐induced Stevens‐Johnson syndrome; Stevens‐Johnson syndrome/toxic epidermal necrolysis from fexofenadine; Memantine‐related drug eruption. Hosp Pharm. 2018;53(4):220‐222. - PMC - PubMed
    1. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17:275‐342. - PubMed

Publication types

LinkOut - more resources